About 230 million people worldwide suffer from peripheral arterial disease (PAD), and the
prevalence is increasing year by year. Multiple risk factors, including smoking, dyslipidemia …

The prevalence of peripheral arterial disease (PAD) in the United States exceeds 10 million
people, and PAD is a significant cause of morbidity and mortality across the globe. PAD is …

Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular
disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying …

Peripheral artery disease (PAD) is caused by occluded or narrowed arteries that reduce
blood flow to the lower limbs. The treatment focuses on lifestyle changes, management of …

Peripheral arterial disease (PAD) is a major health care problem. There have been limited
advances in medical therapies, and a huge burden of symptomatic patients with intermittent …

Peripheral arterial disease (PAD) represents a global health concern with a rising
prevalence attributed to factors such as obesity, diabetes, aging, and smoking. Among …

Patients suffering from both diabetes and PAD (peripheral arterial disease) are at risk of
developing critical limb ischaemia and ulceration, and potentially requiring limb amputation …

Tissue repair requires the orchestration of multiple processes involving a multiplicity of
cellular effectors, signaling pathways, and cell-cell communication. The regeneration of the …

Background: Saving more limbs of patients with peripheral arterial disease (PAD) from
amputation by accelerating angiogenesis in affected limbs has been anticipated for years …

Atherosclerotic peripheral arterial disease (PAD) is a major cause of morbidity in Western
societies and significantly reduces quality of life in affected individuals. 1 The prevalence of …